Ciprofloxacin in Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO): A Population Pharmacokinetic Study
暂无分享,去创建一个
S. Wicha | C. König | S. Kluge | C. Langebrake | M. Baehr | D. Jarczak | O. Frey | D. Alihodzic
[1] H. Endeman,et al. Population pharmacokinetics and target attainment of ciprofloxacin in critically ill patients , 2020, European Journal of Clinical Pharmacology.
[2] S. Wicha,et al. Assessing parameter uncertainty in small-n pharmacometric analyses: value of the log-likelihood profiling-based sampling importance resampling (LLP-SIR) technique , 2020, Journal of Pharmacokinetics and Pharmacodynamics.
[3] S. Wicha,et al. Impact of Inaccurate Documentation of Sampling and Infusion Time in Model-Informed Precision Dosing , 2020, Frontiers in Pharmacology.
[4] U. Fuhr,et al. Ciprofloxacin in critically ill subjects: considering hepatic function, age and sex to choose the optimal dose , 2018, The Journal of antimicrobial chemotherapy.
[5] J. Fraser,et al. Incremental research approach to describing the pharmacokinetics of ciprofloxacin during extracorporeal membrane oxygenation. , 2017, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine.
[6] G. Grasselli,et al. Infections during extracorporeal membrane oxygenation: epidemiology, risk factors, pathogenesis and prevention. , 2017, International journal of antimicrobial agents.
[7] F. Pea,et al. Population Pharmacokinetics and Pharmacodynamics of Levofloxacin in Acutely Hospitalized Older Patients with Various Degrees of Renal Function , 2016, Antimicrobial Agents and Chemotherapy.
[8] J. Fraser,et al. Protein-bound drugs are prone to sequestration in the extracorporeal membrane oxygenation circuit: results from an ex vivo study , 2015, Critical Care.
[9] R J Keizer,et al. Modeling and Simulation Workbench for NONMEM: Tutorial on Pirana, PsN, and Xpose , 2013, CPT: pharmacometrics & systems pharmacology.
[10] J. Heidelbaugh,et al. The perils of prescribing fluoroquinolones. , 2013, The Journal of family practice.
[11] J. Fraser,et al. Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation. , 2012, Journal of critical care.
[12] Kiran Shekar,et al. ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics during Extracorporeal Membrane Oxygenation: a multi-centre study to optimise drug therapy during ECMO , 2012, BMC Anesthesiology.
[13] Kiran Shekar,et al. Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation , 2012, Critical Care.
[14] J. Fraser,et al. ECMO – the clinician’s view , 2012 .
[15] P. Toutain,et al. Optimizing ciprofloxacin dosing in intensive care unit patients through the use of population pharmacokinetic-pharmacodynamic analysis and Monte Carlo simulations. , 2011, The Journal of antimicrobial chemotherapy.
[16] Andrew C. Hooker,et al. Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models , 2011, The AAPS Journal.
[17] J. Stockman,et al. A New Equation to Estimate Glomerular Filtration Rate , 2011 .
[18] R. Ariano,et al. Support for higher ciprofloxacin AUC 24/MIC targets in treating Enterobacteriaceae bloodstream infection. , 2010, The Journal of antimicrobial chemotherapy.
[19] Sandeep Jain,et al. Ciprofloxacin: review on developments in synthetic, analytical, and medicinal aspects , 2010, Journal of enzyme inhibition and medicinal chemistry.
[20] R. Savic,et al. Importance of Shrinkage in Empirical Bayes Estimates for Diagnostics: Problems and Solutions , 2009, The AAPS Journal.
[21] C. Schmid,et al. A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.
[22] J. Roberts,et al. Pharmacokinetic issues for antibiotics in the critically ill patient , 2009, Critical care medicine.
[23] G. Houin,et al. Ciprofloxacin use in critically ill patients: pharmacokinetic and pharmacodynamic approaches. , 2008, International journal of antimicrobial agents.
[24] D. Paterson,et al. Antibiotic resistance—What’s dosing got to do with it? , 2008, Critical care medicine.
[25] N. Holford,et al. Mechanism-based concepts of size and maturity in pharmacokinetics. , 2008, Annual review of pharmacology and toxicology.
[26] Xh Huang,et al. Pharmacokinetic-Pharmacodynamic Modeling and Simulation. , 2007 .
[27] D. Grasela,et al. Pharmacodynamics of Fluoroquinolones against Streptococcus pneumoniae in Patients with Community-Acquired Respiratory Tract Infections , 2001 .
[28] A. Levey,et al. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.
[29] G Sherman,et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. , 1999, Chest.
[30] J. Scribante,et al. Pharmacokinetic Profiles of High-Dose Intravenous Ciprofloxacin in Severe Sepsis , 1998, Antimicrobial Agents and Chemotherapy.
[31] O. Cars,et al. Pharmacokinetics and pharmacodynamics of fluoroquinolones. , 1998, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[32] K. Torniainen,et al. The effect of pH, buffer type and drug concentration on the photodegradation of ciprofloxacin , 1996 .
[33] J. Lettieri,et al. Pharmacokinetics of high-dose intravenous ciprofloxacin in young and elderly and in male and female subjects , 1995, Antimicrobial agents and chemotherapy.
[34] M. Cruciani,et al. The fluoroquinolones as treatment for infections caused by gram-positive bacteria. , 1994, The Journal of antimicrobial chemotherapy.
[35] Jerome J. Schentag,et al. Development of a population pharmacokinetic model and optimal sampling strategies for intravenous ciprofloxacin , 1993, Antimicrobial Agents and Chemotherapy.
[36] J J Schentag,et al. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients , 1993, Antimicrobial Agents and Chemotherapy.
[37] J. Rotschafer,et al. Clinical Pharmacokinetics of Ciprofloxacin , 1990, Clinical pharmacokinetics.
[38] Cockcroft Dw,et al. Prediction of Creatinine Clearance from Serum Creatinine , 1976 .